Following news the Food and Drug Administration has approved CardioMEMS's wireless heart monitoring device, St. Jude Medical Inc. said on Wednesday, May 28th, that it plans complete its acqusition of shares of the biotech company CardioMEMS.
A new technology under development at the Georgia Institute of Technology could one day provide more efficient delivery of the bone regenerating growth factors with greater accuracy and at a lower cost.
Georgia Tech Chemistry and Biochemistry’s Professor M.G. Finn is the new interim chair of the school. With a range of interests from immunology to organic synthesis to materials science, Finn brings something special to this new role.
Andrés García’s lab in the Parker H. Petit Institute for Bioengineering and Bioscience, which deals with really small-sized stuff may be onto something really big, a better way to deliver and protect therapeutic, life-saving cells to people with diabetes.